Kingdon Capital Management, L.L.C. Edwards Lifesciences Corp Transaction History
Kingdon Capital Management, L.L.C.
- $639 Million
- Q2 2025
A detailed history of Kingdon Capital Management, L.L.C. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 91,300 shares of EW stock, worth $7.38 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
91,300Holding current value
$7.38 Million% of portfolio
1.12%Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,450Shares Held
485MCall Options Held
2.76MPut Options Held
1.54M-
Vanguard Group Inc Valley Forge, PA70MShares$5.66 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.12 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.07 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.77 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA19.8MShares$1.6 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $50B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...